|
A.F. Verbovoy 1, E.I. Vorozhtsova 1, T.N. Orlova 2
Metabolic Parameters In Men With Type 2 Diabetes Mellitus And Coronary Artery Disease
|
№9 / 2012
|
|
M.B. Antsiferov 1, A.S. Ametov 2, A.V. Zilov 3
Dpp-4 Inhibitors: Today And Tomorrow. What We Expect From Incretin-stimulating Therapy?
|
№7 / 2012
|
|
M.B. Antsiferov
Dipeptidyl Peptidase-4 Inhibitors In Combination With Metformin: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№7 / 2012
|
|
N. A. Chernikova, M.A. Prudnikova
Timely Administration Of Insulin Therapy In Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
T.V. Nikonova
Sustained-release Metformin (glucophage Long) In The Management Of Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
Ye.V. Biryukova (1), M.B. Antsiferov (2)
How To Effectively Manage Two Major Defects In Type 2 Diabetes Mellitus?
|
№3 / 2012
|
|
O. M. Smirnova, I.V. Kononenko
Sulfonylureas In The Treatment Of Type 2 Diabetes Mellitus Today. Is There A Prospect?
|
№3 / 2012
|
|
M.B. Antsiferov
Application Of Vildagliptin In Combination With Insulin In Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
I.V. Druk, G.I. Nechayeva, O.Yu. Korennova
Sitagliptin: Current Positions And Prospects For Therapy Of Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
M.B. Antsiferov
Glucagon-like Peptide-1: From Physiology To Effective Management Of Type 2 Diabetes Mellitus
|
№3 / 2012
|
|
M.B. Antciferov
Galvus And Galvus Met In Treatment Of Elderly Patients With Type 2 Diabetes Mellitu
|
№16 / 2011
|
|
M.B. Antciferov
Dipeptidyl Peptidase-4 Inhibitors - New Potentials For Treatment Of Type 2 Diabetes Mellitus: Experience Of Use Of Galvus Met In Real-life Clinical Practice In Moscow
|
№16 / 2011
|
Русский
